SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-124699
Filing Date
2021-04-21
Accepted
2021-04-21 16:11:57
Documents
5
Period of Report
2021-06-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A d85377ddef14a.htm DEF 14A 657529
2 GRAPHIC g85377dsp001.jpg GRAPHIC 1273
3 GRAPHIC g85377g22m58.jpg GRAPHIC 51274
4 GRAPHIC g85377g34b74.jpg GRAPHIC 51049
5 GRAPHIC g85377g39o52.jpg GRAPHIC 86790
  Complete submission text file 0001193125-21-124699.txt   921391
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36076 | Film No.: 21841665
SIC: 2836 Biological Products, (No Diagnostic Substances)